BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 35772604)

  • 21. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
    Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
    Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercoagulability of COVID-19 and Neurological Complications: A Review.
    Moore P; Esmail F; Qin S; Nand S; Berg S
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106163. PubMed ID: 34763262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: A Global Threat to the Nervous System.
    Koralnik IJ; Tyler KL
    Ann Neurol; 2020 Jul; 88(1):1-11. PubMed ID: 32506549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2: is there neuroinvasion?
    McQuaid C; Brady M; Deane R
    Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of SARS-CoV-2 on the nervous system.
    Czarnowska A; Zajkowska J; Kułakowska A
    Neurol Neurochir Pol; 2023; 57(1):26-35. PubMed ID: 36799524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system.
    Ostermann PN; Schaal H
    Rev Med Virol; 2023 Mar; 33(2):e2430. PubMed ID: 36790825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System.
    Reza-Zaldívar EE; Hernández-Sapiéns MA; Minjarez B; Gómez-Pinedo U; Márquez-Aguirre AL; Mateos-Díaz JC; Matias-Guiu J; Canales-Aguirre AA
    Front Immunol; 2020; 11():621735. PubMed ID: 33584720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
    Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V
    Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
    Li Z; Liu T; Yang N; Han D; Mi X; Li Y; Liu K; Vuylsteke A; Xiang H; Guo X
    Front Med; 2020 Oct; 14(5):533-541. PubMed ID: 32367431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside.
    Emmi A; Boura I; Raeder V; Mathew D; Sulzer D; Goldman JE; Leta V
    Int Rev Neurobiol; 2022; 165():17-34. PubMed ID: 36208899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.
    Jafari Khaljiri H; Jamalkhah M; Amini Harandi A; Pakdaman H; Moradi M; Mowla A
    Neurotox Res; 2021 Oct; 39(5):1613-1629. PubMed ID: 34169404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up.
    Nersesjan V; Amiri M; Lebech AM; Roed C; Mens H; Russell L; Fonsmark L; Berntsen M; Sigurdsson ST; Carlsen J; Langkilde AR; Martens P; Lund EL; Hansen K; Jespersen B; Folke MN; Meden P; Hejl AM; Wamberg C; Benros ME; Kondziella D
    J Neurol; 2021 Sep; 268(9):3086-3104. PubMed ID: 33438076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nervous system during COVID-19: Caught in the crossfire.
    Natale NR; Lukens JR; Petri WA
    Immunol Rev; 2022 Oct; 311(1):90-111. PubMed ID: 35770683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review.
    Laçinel Gürlevik S; Günbey C; Ozsurekci Y; Oygar PD; Kesici S; Gocmen R; Aydin O; Temucin Ç; Tufan E; Terzi K; Baltu D; Ozturk TT; Teksam O; Ozen S; Oguz KK; Cengiz AB; Yalnızoglu D
    Eur J Paediatr Neurol; 2022 Mar; 37():139-154. PubMed ID: 35287009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system complications in SARS-CoV-2-infected patients.
    Li Z; Lin D; Xu X; Liu X; Zhang J; Huang K; Wang F; Liu J; Zhang Z; Tao E
    J Neurol; 2023 Oct; 270(10):4617-4631. PubMed ID: 37573554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
    Bauer L; van Riel D
    mBio; 2023 Feb; 14(1):e0292022. PubMed ID: 36651750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Manifestations of the central nervous system after COVID-19].
    Gerhard A; Prüß H; Franke C
    Nervenarzt; 2022 Aug; 93(8):769-778. PubMed ID: 35552466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.